BlackRock Science and Technology Term Trust (NASDAQ:BSTZ) Plans $0.16 Monthly Dividend

BlackRock Science and Technology Term Trust (NASDAQ:BSTZ) announced a monthly dividend on Friday, February 27th. Stockholders of record on Friday, May 15th will be paid a dividend of 0.1625 per share on Friday, May 29th. This represents a c) annualized dividend and a dividend yield of 7.0%. The ex-dividend date is Friday, May 15th.

BlackRock Science and Technology Term Trust Stock Down 2.7%

Shares of NASDAQ BSTZ opened at $27.70 on Wednesday. BlackRock Science and Technology Term Trust has a 1 year low of $18.67 and a 1 year high of $28.63. The stock’s 50-day simple moving average is $23.67 and its 200-day simple moving average is $22.94.

Institutional Trading of BlackRock Science and Technology Term Trust

A number of hedge funds have recently made changes to their positions in the stock. US Bancorp DE raised its holdings in BlackRock Science and Technology Term Trust by 165.3% in the third quarter. US Bancorp DE now owns 1,804 shares of the company’s stock valued at $40,000 after acquiring an additional 1,124 shares in the last quarter. Geneos Wealth Management Inc. acquired a new stake in shares of BlackRock Science and Technology Term Trust in the 1st quarter valued at about $40,000. Fifth Third Bancorp acquired a new stake in shares of BlackRock Science and Technology Term Trust in the 1st quarter valued at about $57,000. Kestra Advisory Services LLC bought a new position in shares of BlackRock Science and Technology Term Trust during the fourth quarter worth about $68,000. Finally, Activest Wealth Management acquired a new position in BlackRock Science and Technology Term Trust in the fourth quarter worth about $140,000.

About BlackRock Science and Technology Term Trust

BlackRock Science and Technology Term Trust (NASDAQ: BSTZ) is a closed-end management investment company that provides targeted exposure to companies engaged in the science and technology sectors. Listed on the NASDAQ stock exchange, the trust seeks to deliver total return composed of capital appreciation and monthly distributions over a defined term. It operates as a term trust, with an anticipated liquidation date in August 2028, at which point shareholders will receive proceeds based on the trust’s net asset value.

The trust’s investment strategy is centered on equity and equity-related securities of companies involved in advancing scientific research, technological innovation and related applications.